Overview
Dr. Ralph V. Boccia is a hematologist affiliated with Sibley Memorial Hospital, Suburban Hospital, Shady Grove Adventist Hospital, Holy Cross Hospital and MedStar Georgetown University Hospital, where he is a clinical associate professor of medicine for the University, as well as the medical director of the International Oncology Network (ION) Clinical Research Program and the chairman of ION’s Medical Advisory Panel. He practices out of the Center for Cancer and Blood Disorders, of which he is the founder and medical director, located in Bethesda, Maryland and Germantown, Maryland. Dr. Boccia earned his medical degree from the Autonomous University of Guadalajara School of Medicine. He completed a residency in internal medicine at Kern Medical Center, followed by a fellowship in hematology, oncology and bone marrow transplant at the combined UCLA-Veterans Administration Program and The National Cancer Institute at the National Institutes of Health. Dr. Boccia is a member of the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology and the American Society for Blood and Marrow Transplantation. Dr. Boccia has been listed as a Top Doctor by Washingtonian Magazine and Consumers’ Checkbook Magazine since 1992. He has also been recognized as a Super Doctor by The Washington Post Magazine and a Regional Top Doctor for Washington, D.C., Baltimore and Washington-Baltimore by Castle Connolly. Dr. Boccia has contributed to various articles with his research, published in journals such as Annals of Internal Medicine, Journal of Clinical Oncology and The Lancet. Recent News Articles and Media Coverage Bladder cancer trends in Montgomery and Prince George's counties: Welcome news - and 3 facts you need to know. NJ.com (08/16/2016) RCCA Expands to Maryland to Become One of the Nation's First Multi-State Oncology/Hematology Physician-Owned and -Operated Networks. OncLive (10/06/2015).
Dr. Boccia is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Anemia, Multiple Myeloma, Thrombocytopenia, Adult Immune Thrombocytopenia, and Splenectomy.
His clinical research consists of co-authoring 70 peer reviewed articles and participating in 27 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles and participated in 2 clinical trials in the study of Anemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6410 Rockledge Drive, Suite 660, Suite 660, Bethesda, MD 20817
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
27 Clinical Trials
Phillip Scheinberg is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Scheinberg is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, and Bone Marrow Transplant.
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.
American Oncology Partners PA
Michael Auerbach is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Auerbach is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Iron Deficiency Anemia, Anemia, Hypophosphatemia, and Childhood Iron Deficiency Anemia. Dr. Auerbach is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Immune ThrombocytopeniaDr. Boccia isDistinguished. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Boccia isDistinguished. Learn about Anemia.
- Immune Thrombocytopenic Purpura (ITP)Dr. Boccia isDistinguished. Learn about Immune Thrombocytopenic Purpura (ITP).
- Multiple MyelomaDr. Boccia isDistinguished. Learn about Multiple Myeloma.
- ThrombocytopeniaDr. Boccia isDistinguished. Learn about Thrombocytopenia.
- Advanced
- AgranulocytosisDr. Boccia isAdvanced. Learn about Agranulocytosis.
- Blood ClotsDr. Boccia isAdvanced. Learn about Blood Clots.
- Chronic B-Cell Leukemia (CBCL)Dr. Boccia isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Deep Vein ThrombosisDr. Boccia isAdvanced. Learn about Deep Vein Thrombosis.
- Essential ThrombocythemiaDr. Boccia isAdvanced. Learn about Essential Thrombocythemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Boccia isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- ALK-Positive Non-Small Cell Lung CancerDr. Boccia isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Antiphospholipid SyndromeDr. Boccia isExperienced. Learn about Antiphospholipid Syndrome.
- Arterial EmbolismDr. Boccia isExperienced. Learn about Arterial Embolism.
- Childhood Acute Myeloid LeukemiaDr. Boccia isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Boccia isExperienced. Learn about Chronic Myelogenous Leukemia (CML).